(1->4)-beta-D-glucan multiple interactions ISO Fabp5 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of FABP5 mRNA CTD PMID:36331819 1,2-dichloroethane decreases expression ISO Fabp5 (Mus musculus) 6480464 ethylene dichloride results in decreased expression of FABP5 mRNA CTD PMID:28960355 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of FABP5 mRNA CTD PMID:30723492 17alpha-ethynylestradiol increases expression ISO Fabp5 (Mus musculus) 6480464 Ethinyl Estradiol results in increased expression of FABP5 mRNA CTD PMID:17942748 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of FABP5 mRNA CTD PMID:15576828 and PMID:16174780 17alpha-ethynylestradiol affects expression EXP 6480464 Ethinyl Estradiol affects the expression of FABP5 mRNA CTD PMID:17351261 17alpha-ethynylestradiol multiple interactions ISO Fabp5 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of FABP5 mRNA CTD PMID:17942748 17beta-estradiol decreases expression ISO Fabp5 (Mus musculus) 6480464 Estradiol results in decreased expression of FABP5 mRNA CTD PMID:19484750 17beta-estradiol increases expression ISO FABP5 (Homo sapiens) 6480464 Estradiol results in increased expression of FABP5 mRNA CTD PMID:31614463 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of FABP5 mRNA CTD PMID:32145629 2,2',4,4'-Tetrabromodiphenyl ether decreases expression EXP 6480464 2 more ... CTD PMID:27291303 2,2',4,4'-Tetrabromodiphenyl ether decreases expression ISO Fabp5 (Mus musculus) 6480464 2 more ... CTD PMID:30294300 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO FABP5 (Homo sapiens) 6480464 2 more ... CTD PMID:23146750 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Fabp5 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of FABP5 mRNA CTD PMID:15800033 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of FABP5 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Fabp5 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of FABP5 mRNA CTD PMID:28238261 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Fabp5 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of FABP5 mRNA CTD PMID:16611356 and PMID:26377647 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of FABP5 mRNA CTD PMID:16054898 more ... 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of FABP5 mRNA CTD PMID:11752688 and PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Fabp5 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of FABP5 mRNA CTD PMID:17942748 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:32109520 2,4-dibromophenyl 2,4,5-tribromophenyl ether increases expression ISO Fabp5 (Mus musculus) 6480464 2 more ... CTD PMID:18550172 2,4-dibromophenyl 2,4,5-tribromophenyl ether decreases expression ISO Fabp5 (Mus musculus) 6480464 2 more ... CTD PMID:18550172 2,4-dinitrotoluene affects expression EXP 6480464 2 and 4-dinitrotoluene affects the expression of FABP5 mRNA CTD PMID:21346803 2-butan-2-yl-4-[4-[4-[4-[[2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]phenyl]-1,2,4-triazol-3-one increases expression ISO Fabp5 (Mus musculus) 6480464 Itraconazole results in increased expression of FABP5 mRNA CTD PMID:31099283 2-butoxyethanol increases expression ISO Fabp5 (Mus musculus) 6480464 n-butoxyethanol results in increased expression of FABP5 mRNA CTD PMID:19812364 2-hydroxypropanoic acid increases expression ISO FABP5 (Homo sapiens) 6480464 Lactic Acid results in increased expression of FABP5 mRNA CTD PMID:30851411 2-palmitoylglycerol increases expression ISO FABP5 (Homo sapiens) 6480464 2-palmitoylglycerol results in increased expression of FABP5 mRNA CTD PMID:37199045 3,3',4,4',5-pentachlorobiphenyl increases expression EXP 6480464 3 more ... CTD PMID:20959002 3,3',5-triiodo-L-thyronine increases expression EXP 6480464 Triiodothyronine results in increased expression of FABP5 mRNA CTD PMID:15953391 3,4-methylenedioxymethamphetamine increases expression ISO Fabp5 (Mus musculus) 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine results in increased expression of FABP5 mRNA CTD PMID:20188158 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO Fabp5 (Mus musculus) 6480464 [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of FABP5 mRNA CTD PMID:23428407 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO FABP5 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of FABP5 mRNA CTD PMID:28628672 3H-1,2-dithiole-3-thione increases expression EXP 6480464 1 and 2-dithiol-3-thione results in increased expression of FABP5 mRNA CTD PMID:19162173 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4 and 4'-diaminodiphenylmethane results in increased expression of FABP5 mRNA CTD PMID:30723492 4,4'-sulfonyldiphenol increases expression ISO FABP5 (Homo sapiens) 6480464 bisphenol S results in increased expression of FABP5 mRNA CTD PMID:27685785 4,4'-sulfonyldiphenol multiple interactions ISO FABP5 (Homo sapiens) 6480464 [bisphenol S co-treated with Fulvestrant] results in increased methylation of FABP5 gene CTD PMID:31601247 4,4'-sulfonyldiphenol decreases expression ISO Fabp5 (Mus musculus) 6480464 bisphenol S results in decreased expression of FABP5 mRNA CTD PMID:33297965 5-aza-2'-deoxycytidine multiple interactions ISO FABP5 (Homo sapiens) 6480464 [Decitabine affects the methylation of FABP5 promoter] which affects the expression of FABP5 protein CTD PMID:18636205 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of FABP5 mRNA CTD PMID:24780913 and PMID:30047161 9-cis-retinoic acid decreases expression ISO FABP5 (Homo sapiens) 6480464 Alitretinoin results in decreased expression of FABP5 mRNA CTD PMID:15982314 aflatoxin B1 decreases expression ISO Fabp5 (Mus musculus) 6480464 Aflatoxin B1 results in decreased expression of FABP5 mRNA CTD PMID:19770486 aflatoxin B1 increases expression ISO FABP5 (Homo sapiens) 6480464 Aflatoxin B1 results in increased expression of FABP5 mRNA CTD PMID:22100608 Alisol B multiple interactions ISO Fabp5 (Mus musculus) 6480464 alisol B inhibits the reaction [[Dietary Fats co-treated with Carbon Tetrachloride] results in increased expression of FABP5 mRNA] CTD PMID:35745142 all-trans-4-oxoretinoic acid decreases expression ISO FABP5 (Homo sapiens) 6480464 4-oxoretinoic acid results in decreased expression of FABP5 mRNA CTD PMID:15982314 all-trans-retinoic acid increases expression ISO FABP5 (Homo sapiens) 6480464 Tretinoin metabolite results in increased expression of FABP5 mRNA CTD PMID:15982314 all-trans-retinoic acid decreases expression ISO FABP5 (Homo sapiens) 6480464 Tretinoin results in decreased expression of FABP5 mRNA CTD PMID:15982314 and PMID:23724009 amitrole increases expression EXP 6480464 Amitrole results in increased expression of FABP5 mRNA CTD PMID:30047161 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of FABP5 mRNA CTD PMID:16483693 amphetamine increases expression EXP 6480464 Amphetamine results in increased expression of FABP5 mRNA CTD PMID:30779732 antirheumatic drug increases expression ISO FABP5 (Homo sapiens) 6480464 Antirheumatic Agents results in increased expression of FABP5 mRNA CTD PMID:24449571 arsane multiple interactions ISO FABP5 (Homo sapiens) 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of FABP5 mRNA CTD PMID:32525701 arsenic atom multiple interactions ISO FABP5 (Homo sapiens) 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of FABP5 mRNA CTD PMID:32525701 arsenite(3-) multiple interactions ISO FABP5 (Homo sapiens) 6480464 arsenite promotes the reaction [G3BP1 protein binds to FABP5 mRNA] CTD PMID:32406909 arsenous acid increases expression ISO FABP5 (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of FABP5 mRNA CTD PMID:22521957 benzo[a]pyrene decreases expression ISO FABP5 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of FABP5 mRNA CTD PMID:20064835 benzo[a]pyrene increases methylation ISO FABP5 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased methylation of FABP5 promoter CTD PMID:27901495 benzo[a]pyrene decreases methylation ISO FABP5 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased methylation of FABP5 exon CTD PMID:27901495 benzo[a]pyrene decreases expression ISO Fabp5 (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of FABP5 mRNA CTD PMID:19770486 benzo[b]fluoranthene increases expression ISO Fabp5 (Mus musculus) 6480464 benzo(b)fluoranthene results in increased expression of FABP5 mRNA CTD PMID:26377693 Benzo[k]fluoranthene increases expression ISO Fabp5 (Mus musculus) 6480464 benzo(k)fluoranthene results in increased expression of FABP5 mRNA CTD PMID:26377693 beta-hexachlorocyclohexane increases expression ISO Fabp5 (Mus musculus) 6480464 beta-hexachlorocyclohexane results in increased expression of FABP5 mRNA CTD PMID:28392238 bis(2-chloroethyl) sulfide decreases expression ISO FABP5 (Homo sapiens) 6480464 Mustard Gas results in decreased expression of FABP5 mRNA CTD PMID:25102026 bis(2-ethylhexyl) phthalate increases expression ISO Fabp5 (Mus musculus) 6480464 Diethylhexyl Phthalate results in increased expression of FABP5 mRNA CTD PMID:19850644 bis(2-ethylhexyl) phthalate multiple interactions EXP 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of FABP5 mRNA CTD PMID:31199487 bis(2-ethylhexyl) phthalate decreases expression ISO Fabp5 (Mus musculus) 6480464 Diethylhexyl Phthalate results in decreased expression of FABP5 mRNA CTD PMID:28085963 bis(2-ethylhexyl) phthalate increases expression ISO FABP5 (Homo sapiens) 6480464 Diethylhexyl Phthalate results in increased expression of FABP5 mRNA CTD PMID:28412506 bis(2-ethylhexyl) phthalate multiple interactions ISO Fabp5 (Mus musculus) 6480464 PPARA protein promotes the reaction [Diethylhexyl Phthalate results in increased expression of FABP5 mRNA] CTD PMID:19850644 bisphenol A decreases expression ISO Fabp5 (Mus musculus) 6480464 bisphenol A results in decreased expression of FABP5 protein CTD PMID:24909818 bisphenol A decreases methylation ISO FABP5 (Homo sapiens) 6480464 bisphenol A results in decreased methylation of FABP5 gene CTD PMID:31601247 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of FABP5 protein CTD PMID:32145629 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of FABP5 mRNA CTD PMID:30816183 and PMID:32145629 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of FABP5 mRNA CTD PMID:30903817 bisphenol A affects expression ISO FABP5 (Homo sapiens) 6480464 bisphenol A affects the expression of FABP5 mRNA CTD PMID:30903817 bisphenol A decreases expression ISO FABP5 (Homo sapiens) 6480464 bisphenol A results in decreased expression of FABP5 mRNA CTD PMID:29275510 bisphenol A increases expression ISO Fabp5 (Mus musculus) 6480464 bisphenol A results in increased expression of FABP5 protein CTD PMID:24909818 Brodifacoum decreases expression EXP 6480464 bromfenacoum results in decreased expression of FABP5 protein CTD PMID:28903499 buspirone decreases expression EXP 6480464 Buspirone results in decreased expression of FABP5 mRNA CTD PMID:24136188 butanal increases expression ISO FABP5 (Homo sapiens) 6480464 butyraldehyde results in increased expression of FABP5 mRNA CTD PMID:26079696 Butylbenzyl phthalate multiple interactions EXP 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of FABP5 mRNA CTD PMID:31199487 cadmium atom increases expression EXP 6480464 Cadmium results in increased expression of FABP5 mRNA CTD PMID:17066326 cadmium atom decreases expression ISO FABP5 (Homo sapiens) 6480464 Cadmium results in decreased expression of FABP5 mRNA CTD PMID:31082426 cadmium atom multiple interactions ISO FABP5 (Homo sapiens) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of FABP5 protein CTD PMID:33040242 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of FABP5 mRNA CTD PMID:17066326 cadmium dichloride multiple interactions ISO FABP5 (Homo sapiens) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of FABP5 protein CTD PMID:33040242 calciol decreases expression ISO Fabp5 (Mus musculus) 6480464 Cholecalciferol results in decreased expression of FABP5 mRNA CTD PMID:16508948 capsaicin decreases expression ISO FABP5 (Homo sapiens) 6480464 Capsaicin results in decreased expression of FABP5 mRNA CTD PMID:18533110 carbon nanotube decreases expression ISO FABP5 (Homo sapiens) 6480464 Nanotubes and Carbon results in decreased expression of FABP5 mRNA CTD PMID:24389112 carbon nanotube increases expression ISO Fabp5 (Mus musculus) 6480464 Nanotubes and Carbon analog results in increased expression of FABP5 mRNA CTD PMID:25554681 carbon nanotube decreases expression ISO Fabp5 (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25620056 carbon nanotube affects expression ISO Fabp5 (Mus musculus) 6480464 Nanotubes and Carbon affects the expression of FABP5 mRNA CTD PMID:25554681 carnosic acid decreases expression ISO Fabp5 (Mus musculus) 6480464 salvin results in decreased expression of FABP5 protein CTD PMID:35926579 CGP 52608 multiple interactions ISO FABP5 (Homo sapiens) 6480464 CGP 52608 promotes the reaction [RORA protein binds to FABP5 gene] CTD PMID:28238834 chloropicrin increases expression ISO FABP5 (Homo sapiens) 6480464 chloropicrin results in increased expression of FABP5 mRNA CTD PMID:26352163 and PMID:28476498 choline multiple interactions ISO Fabp5 (Mus musculus) 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in decreased expression of FABP5 mRNA CTD PMID:33549593 choline multiple interactions EXP 6480464 [Folic Acid deficiency co-treated with Methionine deficiency co-treated with Choline deficiency] results in increased expression of FABP5 protein CTD PMID:19566968 ciguatoxin CTX1B affects expression ISO Fabp5 (Mus musculus) 6480464 Ciguatoxins affects the expression of FABP5 mRNA CTD PMID:18353800 cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of FABP5 mRNA CTD PMID:22023808 clofibrate multiple interactions ISO Fabp5 (Mus musculus) 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of FABP5 mRNA and PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of FABP5 mRNA] CTD PMID:17585979 clofibric acid affects expression EXP 6480464 Clofibric Acid affects the expression of FABP5 mRNA CTD PMID:17602206 cobalt dichloride decreases expression ISO FABP5 (Homo sapiens) 6480464 cobaltous chloride results in decreased expression of FABP5 mRNA CTD PMID:19376846 cobalt dichloride increases expression EXP 6480464 cobaltous chloride results in increased expression of FABP5 mRNA and cobaltous chloride results in increased expression of FABP5 protein CTD PMID:24386269 copper atom decreases expression ISO Fabp5 (Mus musculus) 6480464 Copper results in decreased expression of FABP5 mRNA CTD PMID:17205981 copper atom multiple interactions ISO Fabp5 (Mus musculus) 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of FABP5 mRNA CTD PMID:15467011 copper(0) decreases expression ISO Fabp5 (Mus musculus) 6480464 Copper results in decreased expression of FABP5 mRNA CTD PMID:17205981 copper(0) multiple interactions ISO Fabp5 (Mus musculus) 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of FABP5 mRNA CTD PMID:15467011 copper(II) sulfate decreases expression ISO FABP5 (Homo sapiens) 6480464 Copper Sulfate results in decreased expression of FABP5 mRNA CTD PMID:19549813 coumestrol multiple interactions ISO FABP5 (Homo sapiens) 6480464 [Coumestrol co-treated with ESR1 protein] results in increased expression of FABP5 mRNA and ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of FABP5 mRNA] CTD PMID:18310284 cyanocob(III)alamin multiple interactions ISO Fabp5 (Mus musculus) 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in decreased expression of FABP5 mRNA CTD PMID:33549593 dexamethasone multiple interactions ISO Fabp5 (Mus musculus) 6480464 [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of FABP5 mRNA CTD PMID:23428407 dexamethasone decreases expression ISO Fabp5 (Mus musculus) 6480464 Dexamethasone results in decreased expression of FABP5 mRNA CTD PMID:35589016 dexamethasone multiple interactions ISO FABP5 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of FABP5 mRNA CTD PMID:28628672 dexamethasone increases expression ISO FABP5 (Homo sapiens) 6480464 Dexamethasone results in increased expression of FABP5 mRNA CTD PMID:25047013 diarsenic trioxide increases expression ISO FABP5 (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of FABP5 mRNA CTD PMID:22521957 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of FABP5 mRNA CTD PMID:17379624 dibutyl phthalate multiple interactions EXP 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of FABP5 mRNA CTD PMID:31199487 dichlorine multiple interactions EXP 6480464 [Ozone co-treated with Chlorine] results in decreased expression of FABP5 mRNA CTD PMID:18636392 dichloroacetic acid decreases expression ISO Fabp5 (Mus musculus) 6480464 Dichloroacetic Acid results in decreased expression of FABP5 mRNA CTD PMID:28962523 diclofenac increases expression ISO Fabp5 (Mus musculus) 6480464 Diclofenac results in increased expression of FABP5 mRNA CTD PMID:26934552 diethyl phthalate multiple interactions EXP 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of FABP5 mRNA CTD PMID:31199487 diethylstilbestrol increases expression ISO Fabp5 (Mus musculus) 6480464 Diethylstilbestrol results in increased expression of FABP5 mRNA CTD PMID:15171707 difenoconazole decreases expression ISO Fabp5 (Mus musculus) 6480464 difenoconazole results in decreased expression of FABP5 mRNA CTD PMID:34425431 diisobutyl phthalate multiple interactions EXP 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of FABP5 mRNA CTD PMID:31199487 diisononyl phthalate multiple interactions EXP 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of FABP5 mRNA CTD PMID:31199487 dioxygen increases expression EXP 6480464 Oxygen results in increased expression of FABP5 mRNA CTD PMID:22911455 dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate decreases expression ISO FABP5 (Homo sapiens) 6480464 Antimony Potassium Tartrate results in decreased expression of FABP5 mRNA CTD PMID:28713220 diuron increases expression EXP 6480464 Diuron results in increased expression of FABP5 mRNA CTD PMID:21551480 dorsomorphin multiple interactions ISO FABP5 (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin multiple interactions ISO Fabp5 (Mus musculus) 6480464 [[MT1 protein co-treated with MT2 protein] affects the susceptibility to Doxorubicin] which affects the expression of FABP5 mRNA CTD PMID:21040762 doxorubicin increases expression ISO FABP5 (Homo sapiens) 6480464 Doxorubicin results in increased expression of FABP5 mRNA CTD PMID:29803840 doxorubicin decreases expression ISO Fabp5 (Mus musculus) 6480464 Doxorubicin results in decreased expression of FABP5 mRNA CTD PMID:21040762 emodin decreases expression ISO Fabp5 (Mus musculus) 6480464 Emodin results in decreased expression of FABP5 mRNA CTD PMID:15612046 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of FABP5 mRNA CTD PMID:29391264 enzyme inhibitor multiple interactions ISO FABP5 (Homo sapiens) 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of FABP5 protein CTD PMID:23301498 epoxiconazole affects expression ISO Fabp5 (Mus musculus) 6480464 epoxiconazole affects the expression of FABP5 mRNA CTD PMID:35436446 ethanol decreases expression EXP 6480464 Ethanol results in decreased expression of FABP5 mRNA CTD PMID:17920746 ethanol decreases expression ISO Fabp5 (Mus musculus) 6480464 Ethanol results in decreased expression of FABP5 mRNA CTD PMID:19167417 ethyl methanesulfonate decreases expression ISO FABP5 (Homo sapiens) 6480464 Ethyl Methanesulfonate results in decreased expression of FABP5 mRNA CTD PMID:23649840 flutamide increases expression EXP 6480464 Flutamide results in increased expression of FABP5 mRNA CTD PMID:24136188 folic acid multiple interactions ISO Fabp5 (Mus musculus) 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in decreased expression of FABP5 mRNA CTD PMID:33549593 folic acid multiple interactions EXP 6480464 [Folic Acid deficiency co-treated with Methionine deficiency co-treated with Choline deficiency] results in increased expression of FABP5 protein CTD PMID:19566968 fonofos increases methylation ISO FABP5 (Homo sapiens) 6480464 Fonofos results in increased methylation of FABP5 promoter CTD PMID:22847954 fulvestrant multiple interactions ISO FABP5 (Homo sapiens) 6480464 [bisphenol S co-treated with Fulvestrant] results in increased methylation of FABP5 gene CTD PMID:31601247 furan increases expression EXP 6480464 furan results in increased expression of FABP5 mRNA CTD PMID:20124500 and PMID:25539665 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of FABP5 mRNA CTD PMID:33387578 glafenine increases expression EXP 6480464 Glafenine results in increased expression of FABP5 mRNA CTD PMID:24136188 glycine betaine multiple interactions ISO Fabp5 (Mus musculus) 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in decreased expression of FABP5 mRNA CTD PMID:33549593 graphene oxide decreases expression ISO Fabp5 (Mus musculus) 6480464 graphene oxide results in decreased expression of FABP5 mRNA CTD PMID:33227293 hydrogen peroxide affects expression ISO FABP5 (Homo sapiens) 6480464 Hydrogen Peroxide affects the expression of FABP5 mRNA CTD PMID:21179406 indometacin multiple interactions ISO FABP5 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of FABP5 mRNA CTD PMID:28628672 indometacin increases expression EXP 6480464 Indomethacin results in increased expression of FABP5 mRNA CTD PMID:36868495 inulin multiple interactions ISO Fabp5 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of FABP5 mRNA CTD PMID:36331819 isoprenaline increases expression ISO Fabp5 (Mus musculus) 6480464 Isoproterenol results in increased expression of FABP5 mRNA CTD PMID:21335049 isotretinoin decreases expression ISO FABP5 (Homo sapiens) 6480464 Isotretinoin results in decreased expression of FABP5 mRNA CTD PMID:15982314 itraconazole increases expression ISO Fabp5 (Mus musculus) 6480464 Itraconazole results in increased expression of FABP5 mRNA CTD PMID:31099283 ivermectin decreases expression ISO FABP5 (Homo sapiens) 6480464 Ivermectin results in decreased expression of FABP5 protein CTD PMID:32959892 ketoconazole increases expression EXP 6480464 Ketoconazole results in increased expression of FABP5 mRNA CTD PMID:37077353 ketoconazole increases expression ISO Fabp5 (Mus musculus) 6480464 Ketoconazole results in increased expression of FABP5 mRNA CTD PMID:31099283 L-methionine multiple interactions ISO Fabp5 (Mus musculus) 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in decreased expression of FABP5 mRNA CTD PMID:33549593 L-methionine multiple interactions EXP 6480464 [Folic Acid deficiency co-treated with Methionine deficiency co-treated with Choline deficiency] results in increased expression of FABP5 protein CTD PMID:19566968 lead(0) affects binding ISO FABP5 (Homo sapiens) 6480464 FABP5 protein binds to Lead CTD PMID:23896426 lead(0) affects expression ISO FABP5 (Homo sapiens) 6480464 Lead affects the expression of FABP5 mRNA CTD PMID:28903495 melphalan increases expression ISO FABP5 (Homo sapiens) 6480464 Melphalan results in increased expression of FABP5 mRNA CTD PMID:22363485 mercury atom increases expression EXP 6480464 Mercury results in increased expression of FABP5 mRNA CTD PMID:12730625 mercury(0) increases expression EXP 6480464 Mercury results in increased expression of FABP5 mRNA CTD PMID:12730625 methcathinone increases expression ISO FABP5 (Homo sapiens) 6480464 monomethylpropion results in increased expression of FABP5 mRNA CTD PMID:22303338 methimazole increases expression EXP 6480464 Methimazole results in increased expression of FABP5 mRNA CTD PMID:30047161 methyl methanesulfonate decreases expression ISO FABP5 (Homo sapiens) 6480464 Methyl Methanesulfonate results in decreased expression of FABP5 mRNA CTD PMID:23649840 methylisothiazolinone increases expression ISO FABP5 (Homo sapiens) 6480464 2-methyl-4-isothiazolin-3-one results in increased expression of FABP5 mRNA CTD PMID:31629900 methylmercury chloride increases expression ISO FABP5 (Homo sapiens) 6480464 methylmercuric chloride results in increased expression of FABP5 mRNA CTD PMID:28001369 microcystin RR decreases expression ISO FABP5 (Homo sapiens) 6480464 microcystin RR results in decreased expression of FABP5 protein CTD PMID:19111056 monosodium L-glutamate multiple interactions ISO Fabp5 (Mus musculus) 6480464 [Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of FABP5 mRNA CTD PMID:19001666 N-methyl-4-phenylpyridinium increases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in increased expression of FABP5 mRNA CTD PMID:28801915 N-nitrosodiethylamine increases expression EXP 6480464 Diethylnitrosamine results in increased expression of FABP5 mRNA CTD PMID:19638242 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of FABP5 mRNA CTD PMID:28943392 N-nitrosodiethylamine increases expression ISO Fabp5 (Mus musculus) 6480464 Diethylnitrosamine results in increased expression of FABP5 mRNA CTD PMID:24535843 nefazodone decreases expression EXP 6480464 nefazodone results in decreased expression of FABP5 mRNA CTD PMID:24136188 nickel sulfate increases expression ISO FABP5 (Homo sapiens) 6480464 nickel sulfate results in increased expression of FABP5 mRNA CTD PMID:16780908 nickel sulfate decreases expression ISO FABP5 (Homo sapiens) 6480464 nickel sulfate results in decreased expression of FABP5 mRNA CTD PMID:18651567 nimesulide decreases expression EXP 6480464 nimesulide results in decreased expression of FABP5 mRNA CTD PMID:24136188 nitrofen increases expression EXP 6480464 nitrofen results in increased expression of FABP5 mRNA CTD PMID:33484710 ochratoxin A decreases expression EXP 6480464 ochratoxin A results in decreased expression of FABP5 mRNA CTD PMID:16251485 ozone multiple interactions EXP 6480464 [Ozone co-treated with Chlorine] results in decreased expression of FABP5 mRNA CTD PMID:18636392 ozone multiple interactions ISO Fabp5 (Mus musculus) 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of FABP5 mRNA CTD PMID:34911549 paracetamol multiple interactions ISO Fabp5 (Mus musculus) 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of FABP5 mRNA and PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of FABP5 mRNA] CTD PMID:17585979 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of FABP5 mRNA CTD PMID:33387578 paracetamol decreases expression ISO FABP5 (Homo sapiens) 6480464 Acetaminophen results in decreased expression of FABP5 mRNA CTD PMID:21420995 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of FABP5 protein CTD PMID:16538041 paraquat increases expression ISO Fabp5 (Mus musculus) 6480464 Paraquat results in increased expression of FABP5 mRNA CTD PMID:21371552 parathion increases methylation ISO FABP5 (Homo sapiens) 6480464 Parathion results in increased methylation of FABP5 promoter CTD PMID:22847954 perfluorobutyric acid increases expression ISO Fabp5 (Mus musculus) 6480464 perfluorobutyric acid results in increased expression of FABP5 mRNA CTD PMID:34474067 perfluorohexanesulfonic acid increases expression ISO Fabp5 (Mus musculus) 6480464 perfluorohexanesulfonic acid results in increased expression of FABP5 mRNA CTD PMID:37995155 perfluorooctane-1-sulfonic acid affects expression EXP 6480464 perfluorooctane sulfonic acid affects the expression of FABP5 mRNA CTD PMID:19162173 perfluorooctane-1-sulfonic acid multiple interactions ISO Fabp5 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of FABP5 mRNA and [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of FABP5 mRNA CTD PMID:36331819 perfluorooctane-1-sulfonic acid decreases expression ISO Fabp5 (Mus musculus) 6480464 perfluorooctane sulfonic acid results in decreased expression of FABP5 protein CTD PMID:26178269 perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of FABP5 mRNA CTD PMID:19162173 perfluorooctanoic acid decreases expression ISO FABP5 (Homo sapiens) 6480464 perfluorooctanoic acid results in decreased expression of FABP5 mRNA CTD PMID:36326898 phenacetin increases expression EXP 6480464 Phenacetin results in increased expression of FABP5 mRNA CTD PMID:17698508 phenformin decreases expression EXP 6480464 Phenformin results in decreased expression of FABP5 mRNA CTD PMID:31324951 phenobarbital affects expression EXP 6480464 Phenobarbital affects the expression of FABP5 mRNA CTD PMID:19162173 phenobarbital decreases expression ISO Fabp5 (Mus musculus) 6480464 Phenobarbital results in decreased expression of FABP5 mRNA CTD PMID:23091169 phenylhydrazine increases expression EXP 6480464 phenylhydrazine results in increased expression of FABP5 mRNA CTD PMID:17698508 piperonyl butoxide decreases expression EXP 6480464 Piperonyl Butoxide results in decreased expression of FABP5 mRNA CTD PMID:22484513 pirinixic acid increases expression ISO Fabp5 (Mus musculus) 6480464 pirinixic acid results in increased expression of FABP5 mRNA CTD PMID:18301758 pirinixic acid decreases expression ISO Fabp5 (Mus musculus) 6480464 pirinixic acid results in decreased expression of FABP5 mRNA CTD PMID:16985257 more ... pravastatin increases expression ISO Fabp5 (Mus musculus) 6480464 Pravastatin results in increased expression of FABP5 mRNA CTD PMID:27225895 pravastatin increases expression EXP 6480464 Pravastatin results in increased expression of FABP5 mRNA CTD PMID:27225895 pregnenolone 16alpha-carbonitrile decreases expression EXP 6480464 Pregnenolone Carbonitrile results in decreased expression of FABP5 mRNA CTD PMID:19162173 pregnenolone 16alpha-carbonitrile increases expression ISO Fabp5 (Mus musculus) 6480464 Pregnenolone Carbonitrile results in increased expression of FABP5 mRNA CTD PMID:28903501 progesterone decreases expression ISO Fabp5 (Mus musculus) 6480464 Progesterone results in decreased expression of FABP5 mRNA CTD PMID:19693291 propiconazole decreases expression ISO Fabp5 (Mus musculus) 6480464 propiconazole results in decreased expression of FABP5 mRNA CTD PMID:16730040 and PMID:21278054 protein kinase inhibitor multiple interactions ISO FABP5 (Homo sapiens) 6480464 Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of FABP5 mRNA] CTD PMID:28003376 quercetin multiple interactions ISO Fabp5 (Mus musculus) 6480464 [Dietary Fats co-treated with Quercetin] affects the expression of FABP5 mRNA CTD PMID:25047408 quinolin-8-ol decreases expression ISO Fabp5 (Mus musculus) 6480464 Oxyquinoline results in decreased expression of FABP5 mRNA CTD PMID:15612046 rac-lactic acid increases expression ISO FABP5 (Homo sapiens) 6480464 Lactic Acid results in increased expression of FABP5 mRNA CTD PMID:30851411 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of FABP5 mRNA CTD PMID:28374803 sarin decreases expression EXP 6480464 Sarin results in decreased expression of FABP5 protein CTD PMID:28973502 SB 431542 multiple interactions ISO FABP5 (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide increases expression ISO FABP5 (Homo sapiens) 6480464 Silicon Dioxide analog results in increased expression of FABP5 mRNA CTD PMID:25895662 silicon dioxide increases expression ISO Fabp5 (Mus musculus) 6480464 Silicon Dioxide results in increased expression of FABP5 mRNA CTD PMID:29203145 and PMID:29341224 sodium arsenate decreases expression ISO FABP5 (Homo sapiens) 6480464 sodium arsenate results in decreased expression of FABP5 mRNA CTD PMID:12727804 sodium arsenate multiple interactions ISO FABP5 (Homo sapiens) 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of FABP5 mRNA CTD PMID:32525701 sodium arsenite decreases expression ISO FABP5 (Homo sapiens) 6480464 sodium arsenite results in decreased expression of FABP5 mRNA and sodium arsenite results in decreased expression of FABP5 protein CTD PMID:19294697 and PMID:28713220 sodium arsenite decreases expression ISO Fabp5 (Mus musculus) 6480464 sodium arsenite results in decreased expression of FABP5 mRNA CTD PMID:37682722 sodium arsenite affects expression ISO FABP5 (Homo sapiens) 6480464 sodium arsenite affects the expression of FABP5 mRNA CTD PMID:34032870 sodium arsenite increases expression ISO Fabp5 (Mus musculus) 6480464 sodium arsenite results in increased expression of FABP5 mRNA CTD PMID:31532247 sodium arsenite increases expression ISO FABP5 (Homo sapiens) 6480464 sodium arsenite results in increased expression of FABP5 mRNA CTD PMID:28595984 sodium dichromate increases expression EXP 6480464 sodium bichromate results in increased expression of FABP5 mRNA CTD PMID:22561333 sodium dichromate increases expression ISO Fabp5 (Mus musculus) 6480464 sodium bichromate results in increased expression of FABP5 mRNA CTD PMID:31558096 Soman increases expression EXP 6480464 Soman results in increased expression of FABP5 mRNA CTD PMID:19281266 sulfadimethoxine increases expression EXP 6480464 Sulfadimethoxine results in increased expression of FABP5 mRNA CTD PMID:30047161 sunitinib decreases expression ISO FABP5 (Homo sapiens) 6480464 Sunitinib results in decreased expression of FABP5 mRNA CTD PMID:31533062 terbufos increases methylation ISO FABP5 (Homo sapiens) 6480464 terbufos results in increased methylation of FABP5 promoter CTD PMID:22847954 testosterone decreases expression ISO Fabp5 (Mus musculus) 6480464 Testosterone results in decreased expression of FABP5 mRNA CTD PMID:19693291 testosterone increases expression ISO Fabp5 (Mus musculus) 6480464 Testosterone deficiency results in increased expression of FABP5 mRNA CTD PMID:33848595 testosterone multiple interactions ISO Fabp5 (Mus musculus) 6480464 1 more ... CTD PMID:33848595 tetrachloromethane multiple interactions ISO Fabp5 (Mus musculus) 6480464 [Dietary Fats co-treated with Carbon Tetrachloride] results in increased expression of FABP5 mRNA and alisol B inhibits the reaction [[Dietary Fats co-treated with Carbon Tetrachloride] results in increased expression of FABP5 mRNA] CTD PMID:35745142 thalidomide decreases expression ISO Fabp5 (Mus musculus) 6480464 Thalidomide results in decreased expression of FABP5 mRNA CTD PMID:26217789 thioacetamide multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of FABP5 mRNA CTD PMID:28943392 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of FABP5 mRNA CTD PMID:34492290 titanium dioxide increases expression EXP 6480464 titanium dioxide results in increased expression of FABP5 mRNA CTD PMID:30012374 toluene decreases expression EXP 6480464 Toluene results in decreased expression of FABP5 mRNA CTD PMID:22967744 tributylstannane increases expression ISO Fabp5 (Mus musculus) 6480464 tributyltin results in increased expression of FABP5 mRNA CTD PMID:23428407 and PMID:31939706 trichostatin A increases expression ISO FABP5 (Homo sapiens) 6480464 trichostatin A results in increased expression of FABP5 mRNA CTD PMID:24935251 and PMID:26272509 trichostatin A multiple interactions ISO FABP5 (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FABP5 mRNA CTD PMID:27188386 triphenyl phosphate increases expression ISO FABP5 (Homo sapiens) 6480464 triphenyl phosphate results in increased expression of FABP5 mRNA CTD PMID:28934090 triphenyl phosphate decreases expression EXP 6480464 triphenyl phosphate results in decreased expression of FABP5 mRNA CTD PMID:30589522 Triptolide decreases expression ISO Fabp5 (Mus musculus) 6480464 triptolide results in decreased expression of FABP5 mRNA CTD PMID:32835833 troglitazone increases expression ISO Fabp5 (Mus musculus) 6480464 troglitazone results in increased expression of FABP5 mRNA CTD PMID:12732648 and PMID:28973697 tungsten increases expression ISO Fabp5 (Mus musculus) 6480464 Tungsten results in increased expression of FABP5 mRNA CTD PMID:30912803 urethane decreases expression ISO FABP5 (Homo sapiens) 6480464 Urethane results in decreased expression of FABP5 mRNA CTD PMID:28818685 valdecoxib decreases expression EXP 6480464 valdecoxib results in decreased expression of FABP5 mRNA CTD PMID:24136188 valproic acid decreases methylation ISO FABP5 (Homo sapiens) 6480464 Valproic Acid results in decreased methylation of FABP5 gene CTD PMID:29154799 valproic acid multiple interactions ISO FABP5 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FABP5 mRNA CTD PMID:27188386 valproic acid increases expression ISO FABP5 (Homo sapiens) 6480464 Valproic Acid results in increased expression of FABP5 mRNA CTD PMID:23179753 more ... vorinostat multiple interactions ISO FABP5 (Homo sapiens) 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FABP5 mRNA CTD PMID:27188386 zaragozic acid A increases expression ISO Fabp5 (Mus musculus) 6480464 squalestatin 1 results in increased expression of FABP5 mRNA CTD PMID:27225895 zaragozic acid A increases expression EXP 6480464 squalestatin 1 results in increased expression of FABP5 mRNA CTD PMID:27225895 zinc atom decreases expression ISO FABP5 (Homo sapiens) 6480464 Zinc results in decreased expression of FABP5 mRNA CTD PMID:15226459 zinc atom multiple interactions ISO Fabp5 (Mus musculus) 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in decreased expression of FABP5 mRNA CTD PMID:33549593 zinc sulfate decreases expression ISO FABP5 (Homo sapiens) 6480464 Zinc Sulfate results in decreased expression of FABP5 mRNA CTD PMID:15226459 zinc(0) decreases expression ISO FABP5 (Homo sapiens) 6480464 Zinc results in decreased expression of FABP5 mRNA CTD PMID:15226459 zinc(0) multiple interactions ISO Fabp5 (Mus musculus) 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in decreased expression of FABP5 mRNA CTD PMID:33549593